Clinical Research Directory
Browse clinical research sites, groups, and studies.
Intraosseous (IO) Cefazolin and Vancomycin in Primary Total Knee Arthroplasty (TKA)
Sponsor: The Methodist Hospital Research Institute
Summary
The goal of this clinical trial is to compare the efficacy of intravenous (IV) and intraosseous (IO) antibiotic administration techniques during primary total knee arthroplasty (TKA) in adults undergoing a TKA procedure at Houston Methodist Hospital. The main questions it aims to answer are: Does IO administration of vancomycin and cefazolin protect against perioperative exposure risks? Is there a difference in post-operative complication rates between IV and IO administration of these drugs? Participants will be randomized to receive either the standard of care IV administration of Vancomycin and Cefazolin, or the IO administration of Vancomycin and Cefazolin.
Official title: Intraosseous Vancomycin and Cefazolin vs Intravenous Administration in Primary Total Knee Arthroplasty
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
40
Start Date
2025-05-15
Completion Date
2035-12-01
Last Updated
2025-05-18
Healthy Volunteers
No
Conditions
Interventions
IO Administration of Cefazolin
Intraosseous injection of cefazolin to guard against infection.
IO Administration of Vancomycin
Intraosseous injection of vancomycin to guard against infection.
IV Administration of Cefazolin
Intravenous dose of cefazolin to guard against infection.
IV Administration of Vancomycin
Intravenous dose of vancomycin to guard against infection.
Locations (1)
Houston Methodist Hospital
Houston, Texas, United States